The automatic implantable cardioverter defibrillator: Efficacy, complications and survival in patients with malignant ventricular arrhythmias

Patricia A. Kelly, David S. Cannom, Hasan Garan, Gloria S. Mirabal, J. Warren Harthorne, Richard J. Hurvitz, Gus J. Vlahakes, Marshall L. Jacobs, Joseph P. Ilvento, Mortimer J. Buckley, Jeremy N. Ruskin

Research output: Contribution to journalArticlepeer-review

Abstract

Ninety-four patients underwent surgery for automatic implanlable cardioverter-defibrillator implantation. Ninety patients were discharged from the hospital with the device and were followed up for a mean period of 17 ± 10 months. Forty-six patients experienced at least one discharge of the device under circumstances consistent with a malignant ventricular arrhythmia. One sudden death occurred. Complications included perioperative death (3 patients), post-operative ventricular tachycardia (12 patients) and atrial fibrillation (8 patients), perioperative myocardial infarction (1 patient) and device discharges for sinus tachycardia and supraventricular arrhythmias (17 patients). Six and 12 month survival rates by life table analysis were 98.7 and 95.4%, respectively. Thus, the automatic implantable cardioverter-defibrillator is a highly effective and relatively low risk treatment modality for patients with refractory life-threatening ventricular arrhythmias.

Original languageEnglish (US)
Pages (from-to)1278-1286
Number of pages9
JournalJournal of the American College of Cardiology
Volume11
Issue number6
DOIs
StatePublished - Jun 1988
Externally publishedYes

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'The automatic implantable cardioverter defibrillator: Efficacy, complications and survival in patients with malignant ventricular arrhythmias'. Together they form a unique fingerprint.

Cite this